The FDA cleared four notable therapies within the same week in late August, spanning infectious disease, cardiometabolic care ...

In December 2025, FDA announced that it was deploying agentic AI capabilities across the agency. FDA defined these systems as ...

This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...

Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

Continuous direct compression can provide a simplified alternative pathway for selected spray-dried dispersion formulations ...

FDA approves Rasonque (daraxonrasib), the first broad RAS-targeted therapy for metastatic pancreatic cancer, validating RAS ...

On August 19,2026, the FDA accepted Teva Pharmaceuticals' New Drug Application (NDA) for ecopipam, an investigational ...

In part 2 of his overview on hold times in biopharmaceuticals, Robert Dream details the regulations that govern hold times ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications.

Schmitt and Schniepp stress that merely citing a standard (e.g., "we followed GAMP") doesn't guarantee compliance. According ...

McKesson plans to absorb Precision Medicine Group into Oncology & Multispecialty, adding CRO, lab, biomarker, market access, and commercialization capabilities to its existing healthcare services ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization. To formulate a ...